
CRISPR knockout cell lines are engineered through targeted genome editing to eliminate gene function, supporting studies of cellular biology, disease mechanisms, and drug discovery.
Entpd1 (ectonucleoside triphosphate diphosphohydrolase 1) encodes an ectonucleotidase with ADP phosphatase and ribonucleoside triphosphate phosphatase activities. It contributes to nucleotide catabolism, G protein-coupled receptor signaling, and platelet activation. The protein is active on the external surface of the plasma membrane. Its human ortholog, ENTPD1, has been implicated in hereditary spastic paraplegia 64.
UMR-106 is a rat osteosarcoma cell line derived as a clonal derivative of a transplantable osteogenic sarcoma induced by radiophosphorus (³²P). The cells retain characteristics of the original tumor, including responsiveness to parathyroid hormone (PTH) and prostaglandins. UMR-106 is used as a model for studying bone tumor biology, osteoblast-related signaling, and skeletal regulation mechanisms.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: E1
Reference Transcript: Enpp1-201
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?